IRMA-International.org: Creator of Knowledge
Information Resources Management Association
Advancing the Concepts & Practices of Information Resources Management in Modern Organizations

AI-Driven Decision-Making Applications in Pharmaceutical Sciences

AI-Driven Decision-Making Applications in Pharmaceutical Sciences
View Sample PDF
Author(s): Bancha Yingngam (Faculty of Pharmaceutical Sciences, Ubon Ratchathani University, Thailand), Abhiruj Navabhatra (College of Pharmacy, Rangsit University, Thailand)and Polpan Sillapapibool (Faculty of Pharmaceutical Sciences, Ubon Ratchathani University, Thailand)
Copyright: 2024
Pages: 63
Source title: Using Traditional Design Methods to Enhance AI-Driven Decision Making
Source Author(s)/Editor(s): Tien V. T. Nguyen (Industrial University of Ho Chi Minh City, Vietnam)and Nhut T. M. Vo (National Kaohsiung University of Science and Technology, Taiwan)
DOI: 10.4018/979-8-3693-0639-0.ch001

Purchase

View AI-Driven Decision-Making Applications in Pharmaceutical Sciences on the publisher's website for pricing and purchasing information.

Abstract

This chapter explores AI's influence on pharmaceutical sciences, highlighting its enhancement of traditional design methodologies. It explores AI's transformational role in key sectors, including drug discovery, virtual screening, and drug formulation development. AI's ability to efficiently identify potential drug candidates from large chemical libraries and its use of optimization algorithms in the selection of suitable excipients and dosage forms are discussed. The chapter also emphasizes AI's significance in improving pharmaceutical manufacturing processes through parameter refinement, quality outcome prediction, and real-time anomaly detection. The integration of traditional design methods with AI ensures robust, reliable, AI-driven processes that are compliant with regulations. In conclusion, the chapter highlights the potential of AI in pharmaceutical sciences and the importance of its integration with traditional design methods. This approach empowers scientists to innovate, speed up drug development, and improve patient outcomes.

Related Content

Kamel Mouloudj, Vu Lan Oanh LE, Achouak Bouarar, Ahmed Chemseddine Bouarar, Dachel Martínez Asanza, Mayuri Srivastava. © 2024. 20 pages.
José Eduardo Aleixo, José Luís Reis, Sandrina Francisca Teixeira, Ana Pinto de Lima. © 2024. 52 pages.
Jorge Figueiredo, Isabel Oliveira, Sérgio Silva, Margarida Pocinho, António Cardoso, Manuel Pereira. © 2024. 24 pages.
Fatih Pinarbasi. © 2024. 20 pages.
Stavros Kaperonis. © 2024. 25 pages.
Thomas Rui Mendes, Ana Cristina Antunes. © 2024. 24 pages.
Nuno Geada. © 2024. 12 pages.
Body Bottom